Clinical trial
A Phase 3, Double Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of Alfuzosin in Treating Men With ED and Mild LUTS.
NCT00893113 is registered in ClinicalTrials.gov with Chesapeake Urology Research Associates as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3, Double Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of Alfuzosin in Treating Men With ED and Mild LUTS.
- Lead sponsor
- Chesapeake Urology Research Associates
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 30, 2009
- Completion date
- October 31, 2012
- Enrollment
- 74 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.